Lorenzo Agostini, PhD is an R&D scientist, strategy consultant, and investment researcher with five years of experience at the intersection of biotechnology, healthcare strategy, and finance. He has authored peer-reviewed publications, advised government health leaders, and contributed to startup incubators and venture capital series. As an independent analyst (FINRA SIE certified), he shares life sciences investment insights at agostinilorenzo.com.

Currently, Lorenzo is a Postdoctoral Fellow at the National Institutes of Health (NIH) — the world’s largest public funder of biomedical research — where he leads translational pharmacology projects across immunology, neurology, and skeletal disease. He also serves as an ad hoc reviewer for journals published by Nature and Wiley. Previously, he worked as a Business Associate and Strategy Consultant at NTP Biotech, a healthcare venture affiliated with PNK Farmaceutici, where he supported market entry strategies and commercial development efforts.

Lorenzo holds a PhD in Biochemistry from Ludwig-Maximilians-Universität München (Germany), where he studied cellular homeostasis using structural biology (cryo-EM), and an M.Sc. in Industrial Biotechnology from the University of Bologna (Italy)